Characterization of ouabain-like immunoreactivity in human urine

Journal of Hypertension

Volumn 14, Issue 5, 1996, Pages 623-628

  Worgall, Stefan ^a   Hänze, Joerg ^a   Wagner, Roswitha ^a   Peiser, Christian ^b   Lang, Rudolf E ^b   Sulyok, Endre ^a   Rascher, Wolfgang ^a,c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Essential hypertension; High performance liquid chromatography; Ouabain; Radioimmunoassay; Sodium

Indexed keywords

2 PROPANOL; ACETONITRILE; DIGITALIS LIKE FACTOR; OUABAIN; PROPANOL;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DILUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

EID: 0029982326     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199605000-00012     Document Type: Article

References (28)

1. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al.: Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991, 88:6259-6263.
2. Ludens JH, Clark MA, DuCharme DW, Harris DW, Lutzke BS, Mandel F, et al.: Purification of an endogenous digitalis like factor from human plasma for structural analysis. Hypertension 1991, 17:923-929.
3. Boulanger BR, Lilly MP, Hamlyn JM, Laredo J, Shurtleff D, Gann DS: Ouabain is secreted by the adrenal gland In awake dogs. Am J Physiol 1993, 264:E413-E419.
4. Laredo J, Hamilton BP, Hamlyn JM: Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994, 135:794-797.
5. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamlyn JM: Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992, 86:420-425.
6. Hamlyn JM, Manunta P: Ouabain, digitalis-like factors and hypertension. J Hypertens 1992, 10:S99-S111.
7. Lewis LK, Yandie TG, Lewis JG, Richards AM, Pidgeon GB, Kaaja RJ, et al.: Ouabain is not detectable In human plasma. Hypertension 1994, 24:549-555.
8. Gomez-Sanchez EP, Foecking MF, Sellers D, Blankenship MS, Gomez-Sanchez CE: Is the circulating ouabain-like compound ouabain? Am J Hypertens 1994, 7:647-650.
9. Butler VP, Tse-Eng D: Immunoassay of digoxin and of the cardiac glycosides. Methods Enzymol 1982, 84:558-573.
10. Gruber KA, Whitaker JM, Buckalew VM: Endogenous digititalis-like substance In plasma of volume expanded dogs. Nature 1980, 287:743-745.
11. Craver JL, Valdes R: Anomalous serum digoxin concentrations in uremia. Ann Intern Med 1983, 98:483-484.
12. Goto A, Yamada K, Ishii M, Sugimoto T: Release of endogenous digitalis-like factor with sodium loading. N Engl J Med 1989, 320:124-125.
13. 2+ stores and cell responsiveness. Am J Physiol 1993, 264: C1367-C1387.
14. Masugi F, Ogihara T, Hasegawa T, Sakaguchi K, Kumuhara Y: Normalisation of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma. J Hum Hypertens 1988, 2:17-20.
15. Hamilton BP, Manunta P, Laredo JM, Hamilton JH, Hamlyn JM: The new adrenal steroid hormone ouabain. Curr Opin Endocrinol Diabetes 1994, 1:123-131.
16. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, et al.: Long term ouabain administration produces hypertension in rats. Hypertension 1993, 22:178-187.
17. Yasujima M, Abe K, Tanno M, Kohzuki M, Kasai Y, Sato M, et al.: Effects of ouabain on blood pressure regulation in rats. J Hypertens 1986, 4:597-601.
18. Sekihara H, Yazaki Y, Kojima T: Ouabain as an amplifier of mineralocorticoid-induced hypertension. Endocrinology 1992, 131:3077-3082.
19. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, et al.: Physiochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A 1993, 90:8189-8193.
20. Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, et al.: Identification of digitalis-like compounds In human cataractous lenses. Eur J Biochem 1993, 216:261-268.
21. Naruse K, Naruse M, Tanabe A, Yoshimoto T, Watanabe Y, Kurimoto F, et al.: Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension 1994, 23 (suppl I):I102-I105.
22. Selden R, Smith TW: Ouabain pharmacokinetics in dog and man. Circulation 1972, 45:1176-1182.
23. Doris PA: Ouabain in plasma of spontaneously hypertensive rats. Am J Physiol 1994, 266:H360-H364.
24. Weinberg U, Dolev S, Werber MM, Shapiro MS, Shilo L, Shenkman L: Identification and preliminary characterization of two human digitalis-like substances that are structurally related to digoxin and ouabain. Biochem Biophys Res Commun 1992, 188:1024-1029.
25. Weiler EWJ, Genick HC, Prince BA, Purdy RE, Weber MA: Characterization of a low molecular Na,K-ATPase inhibitor of urinary origin. Am J Med Sci 1994, 307:27-35.
26. Tamura M, Harris TM, Konishi F, Inagami T: Isolation and characterization of an endogenous Na,K-ATPase-specific inhibitor from pig urine. Eur J Biochem 1993, 211:317-327.
27. Tamura M, Naruse M, Sakakibara M, Inagami T: Isolation of an endogenous Na-pump-specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands. Biochim Biophys Acta 1993, 1157:15-21.
28. Katzung BG, Parmley WW: Cardiac glycosides and other drugs used in the treatment of congestive heart failure. In Basic and Clinical Pharmacology. Edited by Katzung BG. Norwalk, CN: Appleton and Lange; 1987:138-150.